Novartis's Cosentyx Fails To EXCEED Humira in PsA

'Narrowly Missed' Statistical Significance

 
• By Kevin Grogan
  
Fencing
Mixed results from Cosentyx and Humira head-to-head • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D